Atorvastatin reduces alloxan-induced impairment of aversive stimulus memory in mice

[1] Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016; 92(1084):63–9. ZaccardiF WebbDR YatesT DaviesMJ Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective Postgrad Med J 2016 92 1084 63 9 10.1136/postgradmedj-2015-13328126621825 Search in Google Scholar

[2] American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care 2017; 40(Suppl 1):S11–24. American Diabetes Association 2. Classification and diagnosis of diabetes Diabetes Care 2017 40 Suppl 1 S11 24 10.2337/dc17-S00527979889 Search in Google Scholar

[3] Zimmet P, Alberti KG, Magliano DJ, Bennett PH. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol. 2016; 12:616–22. ZimmetP AlbertiKG MaglianoDJ BennettPH Diabetes mellitus statistics on prevalence and mortality: facts and fallacies Nat Rev Endocrinol 2016 12 616 22 10.1038/nrendo.2016.10527388988 Search in Google Scholar

[4] Selvarajah D, Tesfaye S. Central nervous system involvement in diabetes mellitus. Curr Diab Rep. 2006; 6:431–8. SelvarajahD TesfayeS Central nervous system involvement in diabetes mellitus Curr Diab Rep 2006 6 431 8 10.1007/s11892-006-0075-y17118225 Search in Google Scholar

[5] Tumminia A, Vinciguerra F, Parisi M, Frittitta L. Type 2 diabetes mellitus and Alzheimer's disease: role of insulin signalling and therapeutic implications. Int J Mol Sci. 2018; 19:3306. doi: 10.3390/ijms19113306 TumminiaA VinciguerraF ParisiM FrittittaL Type 2 diabetes mellitus and Alzheimer's disease: role of insulin signalling and therapeutic implications Int J Mol Sci 2018 19 3306 10.3390/ijms19113306 627502530355995 Open DOISearch in Google Scholar

[6] Saedi E, Gheini MR, Faiz F, Arami MA. Diabetes mellitus and cognitive impairments. World J Diabetes. 2016; 7:412–22. SaediE GheiniMR FaizF AramiMA Diabetes mellitus and cognitive impairments World J Diabetes 2016 7 412 22 10.4239/wjd.v7.i17.412502700527660698 Search in Google Scholar

[7] Pugazhenthi S, Qin L, Reddy PH. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. Biochim Biophys Acta Mol Basis Dis. 2017; 1863:1037–45. PugazhenthiS QinL ReddyPH Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease Biochim Biophys Acta Mol Basis Dis 2017 1863 1037 45 10.1016/j.bbadis.2016.04.017534477127156888 Search in Google Scholar

[8] de la Monte SM. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res. 2012; 9:35–66. de la MonteSM Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease Curr Alzheimer Res 2012 9 35 66 10.2174/156720512799015037334998522329651 Search in Google Scholar

[9] Chornenkyy Y, Wang W-X, Wei A, Nelson PT. Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline. Brain Pathol. 2019; 29:3–17. ChornenkyyY WangW-X WeiA NelsonPT Alzheimer's disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline Brain Pathol 2019 29 3 17 10.1111/bpa.12655642791930106209 Search in Google Scholar

[10] Baglietto-Vargas D, Shi J, Yaeger DM, Ager R, LaFerla FM. Diabetes and Alzheimer's disease crosstalk. Neurosci Biobehav Rev. 2016; 64:272–87. Baglietto-VargasD ShiJ YaegerDM AgerR LaFerlaFM Diabetes and Alzheimer's disease crosstalk Neurosci Biobehav Rev 2016 64 272 87 10.1016/j.neubiorev.2016.03.00526969101 Search in Google Scholar

[11] Salas IH, De Strooper B. Diabetes and Alzheimer's disease: a link not as simple as it seems. Neurochem Res. 2019; 44:1271–8. SalasIH De StrooperB Diabetes and Alzheimer's disease: a link not as simple as it seems Neurochem Res 2019 44 1271 8 10.1007/s11064-018-2690-930523576 Search in Google Scholar

[12] Ryan CM, van Duinkerken E, Rosano C. Neurocognitive consequences of diabetes. Am Psychol. 2016; 71:563–76. RyanCM van DuinkerkenE RosanoC Neurocognitive consequences of diabetes Am Psychol 2016 71 563 76 10.1037/a004045527690485 Search in Google Scholar

[13] Gabbouj S, Ryhänen S, Marttinen M, Wittrahm R, Takalo M, Kemppainen S, et al. Altered insulin signaling in Alzheimer's disease brain – special emphasis on PI3K-Akt Pathway. Front Neurosci. 2019; 13:629. doi: 10.3389/fnins.2019.00629 GabboujS RyhänenS MarttinenM WittrahmR TakaloM KemppainenS Altered insulin signaling in Alzheimer's disease brain – special emphasis on PI3K-Akt Pathway Front Neurosci 2019 13 629 10.3389/fnins.2019.00629 659147031275108 Open DOISearch in Google Scholar

[14] Stanley M, Macauley SL, Holtzman DM. Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence? J Exp Med. 2016; 213:1375–85. StanleyM MacauleySL HoltzmanDM Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence? J Exp Med 2016 213 1375 85 10.1084/jem.20160493498653727432942 Search in Google Scholar

[15] Sun Y, Ma C, Sun H, Wang H, Peng W, Zhou Z, et al. Metabolism: a novel shared link between diabetes mellitus and Alzheimer's disease. J Diabetes Res. 2020; 2000:4981814. doi: 10.1155/2020/4981814 SunY MaC SunH WangH PengW ZhouZ Metabolism: a novel shared link between diabetes mellitus and Alzheimer's disease J Diabetes Res 2020 2000 4981814 10.1155/2020/4981814 701148132083135 Open DOISearch in Google Scholar

[16] Muriach M, Flores-Bellver M, Romero FJ, Barcia JM. Diabetes and the brain: oxidative stress, inflammation, and autophagy. Oxid Med Cell Longev. 2014; 2014:102158. doi: 10.1155/2014/102158 MuriachM Flores-BellverM RomeroFJ BarciaJM Diabetes and the brain: oxidative stress, inflammation, and autophagy Oxid Med Cell Longev 2014 2014 102158 10.1155/2014/102158 415855925215171 Open DOISearch in Google Scholar

[17] Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008; 51:216–26. LenzenS The mechanisms of alloxan- and streptozotocin-induced diabetes Diabetologia 2008 51 216 26 10.1007/s00125-007-0886-718087688 Search in Google Scholar

[18] Zhou F, Tan Y, Chen X-H, Wu F-L, Yang D-J, Zhang X-W, et al. Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway. Eur Rev Med Pharmacol Sci. 2018; 22:1142–9. ZhouF TanY ChenX-H WuF-L YangD-J ZhangX-W Atorvastatin improves plaque stability in diabetic atherosclerosis through the RAGE pathway Eur Rev Med Pharmacol Sci 2018 22 1142 9 Search in Google Scholar

[19] Paseban M, Mohebbati R, Niazmand S, Sathyapalan T, Sahebkar A. Comparison of the neuroprotective effects of aspirin, atorvastatin, captopril and metformin in diabetes mellitus. Biomolecules. 2019; 9:118. doi: 10.3390/biom9040118 PasebanM MohebbatiR NiazmandS SathyapalanT SahebkarA Comparison of the neuroprotective effects of aspirin, atorvastatin, captopril and metformin in diabetes mellitus Biomolecules 2019 9 118 10.3390/biom9040118 652335930934759 Open DOISearch in Google Scholar

[20] Pistollato F, Iglesias RC, Ruiz R, Aparicio S, Crespo J, Lopez LD, et al. Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies. Pharmacol Res. 2018; 131:32–43. PistollatoF IglesiasRC RuizR AparicioS CrespoJ LopezLD Nutritional patterns associated with the maintenance of neurocognitive functions and the risk of dementia and Alzheimer's disease: a focus on human studies Pharmacol Res 2018 131 32 43 10.1016/j.phrs.2018.03.01229555333 Search in Google Scholar

[21] Chu C-S, Tseng P-T, Stubbs B, Chen T-Y, Tang C-H, Li D-J, et al. Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis. Sci Rep. 2018; 8:5804. doi: 10.1038/s41598-018-24248-8 ChuC-S TsengP-T StubbsB ChenT-Y TangC-H LiD-J Use of statins and the risk of dementia and mild cognitive impairment: a systematic review and meta-analysis Sci Rep 2018 8 5804 10.1038/s41598-018-24248-8 589561729643479 Open DOISearch in Google Scholar

[22] Kaviani E, Rahmani M, Kaeidi A, Shamsizadeh A, Allahtavakoli M, Mozafari N, Fatemi I. Protective effect of atorvastatin on D-galactose-induced aging model in mice. Behav Brain Res. 2017; 334:55–60. KavianiE RahmaniM KaeidiA ShamsizadehA AllahtavakoliM MozafariN FatemiI Protective effect of atorvastatin on D-galactose-induced aging model in mice Behav Brain Res 2017 334 55 60 10.1016/j.bbr.2017.07.02928750834 Search in Google Scholar

[23] Schultz BG, Patten DK, Berlau DJ. The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms. Transl Neurodegener. 2018; 7:5. doi: 10.1186/s40035-018-0110-3 SchultzBG PattenDK BerlauDJ The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms Transl Neurodegener 2018 7 5 10.1186/s40035-018-0110-3 583005629507718 Open DOISearch in Google Scholar

[24] Samaras K, Makkar SR, Crawford JD, Kochan NA, Slavin MJ, Wen W, et al. Effects of statins on memory, cognition, and brain volume in the elderly. J Am Coll Cardiol. 2019; 74:2554–68. SamarasK MakkarSR CrawfordJD KochanNA SlavinMJ WenW Effects of statins on memory, cognition, and brain volume in the elderly J Am Coll Cardiol 2019 74 2554 68 10.1016/j.jacc.2019.09.04131753200 Search in Google Scholar

[25] Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, et al. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research. PLoS Biology 2020; 18:e3000410. doi: 10.1371/journal.pbio.3000410 Percie du SertN HurstV AhluwaliaA AlamS AveyMT BakerM The ARRIVE guidelines 2.0: updated guidelines for reporting animal research PLoS Biology 2020 18 e3000410 10.1371/journal.pbio.3000410 736002332663219 Open DOISearch in Google Scholar

[26] Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health Prof. 2021; 18:17. doi: 10.3352/jeehp.2021.18.17 KangH Sample size determination and power analysis using the G*Power software J Educ Eval Health Prof 2021 18 17 10.3352/jeehp.2021.18.17 844109634325496 Open DOISearch in Google Scholar

[27] Burkholder T, Foltz C, Karlsson E, Linton CG, Smith JM. Health Evaluation of Experimental Laboratory Mice. Curr Protoc Mouse Biol. 2012; 2:145–65. BurkholderT FoltzC KarlssonE LintonCG SmithJM Health Evaluation of Experimental Laboratory Mice Curr Protoc Mouse Biol 2012 2 145 65 10.1002/9780470942390.mo110217339954522822473 Search in Google Scholar

[28] Tuorkey MJ. Effects of Moringa oleifera aqueous leaf extract in alloxan induced diabetic mice. Interv Med Appl Sci. 2016; 8:109–17. TuorkeyMJ Effects of Moringa oleifera aqueous leaf extract in alloxan induced diabetic mice Interv Med Appl Sci 2016 8 109 17 Search in Google Scholar

[29] Biswas RR, M C D, Rao A S R S, Kadali SRM. Effect of atorvastatin on memory in albino mice. J Clin Diagn Res. 2014; 8:HF01–4. BiswasRR DM C RaoA S R S KadaliSRM Effect of atorvastatin on memory in albino mice J Clin Diagn Res 2014 8 HF01 4 10.7860/JCDR/2014/9730.5089429026325584244 Search in Google Scholar

[30] Georgieva-Kotetarova MT, Kostadinova, II. Effect of atorvastatin and rosuvastatin on learning and memory in rats with diazepam-induced amnesia. Folia Med (Plovdiv) 2013; 55:58–65. Georgieva-KotetarovaMT KostadinovaII Effect of atorvastatin and rosuvastatin on learning and memory in rats with diazepam-induced amnesia Folia Med (Plovdiv) 2013 55 58 65 10.2478/folmed-2013-001824191400 Search in Google Scholar

[31] Vandresen-Filho S, França LM, Alcantara-Junior J, Nogueira LC, de Brito TM, Lopes L, et al. Statins enhance cognitive performance in object location test in albino Swiss mice: involvement of beta-adrenoceptors. Physiol Behav. 2015; 143:27–34. Vandresen-FilhoS FrançaLM Alcantara-JuniorJ NogueiraLC de BritoTM LopesL Statins enhance cognitive performance in object location test in albino Swiss mice: involvement of beta-adrenoceptors Physiol Behav 2015 143 27 34 10.1016/j.physbeh.2015.02.02425700896 Search in Google Scholar

[32] Bugáňová M, Pelantová H, Holubová M, Šedivá B, Maletínská L, Železná B, et al. The effects of liraglutide in mice with diet-induced obesity studied by metabolomics. J Endocrinol. 2017; 233:93–104. BugáňováM PelantováH HolubováM ŠediváB MaletínskáL ŽeleznáB The effects of liraglutide in mice with diet-induced obesity studied by metabolomics J Endocrinol 2017 233 93 104 10.1530/JOE-16-047828138003 Search in Google Scholar

[33] Knudsen LB. Liraglutide: the therapeutic promise from animal models. Int J Clin Pract Suppl. 2010; (167):4–11. KnudsenLB Liraglutide: the therapeutic promise from animal models Int J Clin Pract Suppl 2010 167 4 11 10.1111/j.1742-1241.2010.02499.x20887299 Search in Google Scholar

[34] Andrikopoulos S, Blair AR, Deluca N, Fam BC, Proietto J. Evaluating the glucose tolerance test in mice. Am J Physiol Endocrinol Metab. 2008; 295:E1323–32. doi: 10.1152/ajpendo.90617.2008 AndrikopoulosS BlairAR DelucaN FamBC ProiettoJ Evaluating the glucose tolerance test in mice Am J Physiol Endocrinol Metab 2008 295 E1323 32 10.1152/ajpendo.90617.2008 18812462 Open DOISearch in Google Scholar

[35] Du L, Liu C, Teng M, Meng Q, Lu J, Zhou Y, et al. Anti-diabetic activities of Paecilomyces tenuipes N45 extract in alloxan-induced diabetic mice. Mol Med Rep. 2016; 13:1701–8. DuL LiuC TengM MengQ LuJ ZhouY Anti-diabetic activities of Paecilomyces tenuipes N45 extract in alloxan-induced diabetic mice Mol Med Rep 2016 13 1701 8 10.3892/mmr.2015.473626718133 Search in Google Scholar

[36] Eagle AL, Wang H, Robison AJ. Sensitive assessment of hippocampal learning using temporally dissociated passive avoidance task. Bio Protoc. 2016; 6:e1821. doi: 10.21769/BioProtoc.1821 EagleAL WangH RobisonAJ Sensitive assessment of hippocampal learning using temporally dissociated passive avoidance task Bio Protoc 2016 6 e1821 10.21769/BioProtoc.1821 567262829119127 Open DOISearch in Google Scholar

[37] Damián JP, Acosta V, Da Cuña M, Ramírez I, Oddone N, Zambrana A, et al. Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests. Exp Anim. 2014; 63:277–87. DamiánJP AcostaV Da CuñaM RamírezI OddoneN ZambranaA Effect of resveratrol on behavioral performance of streptozotocin-induced diabetic mice in anxiety tests Exp Anim 2014 63 277 87 10.1538/expanim.63.277420673125077757 Search in Google Scholar

[38] Bösel J, Gandor F, Harms C, Synowitz M, Harms U, Djoufack PC, et al. Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. J Neurochem. 2005; 92:1386–98. BöselJ GandorF HarmsC SynowitzM HarmsU DjoufackPC Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones J Neurochem 2005 92 1386 98 10.1111/j.1471-4159.2004.02980.x15748157 Search in Google Scholar

[39] Lu D, Shen L, Mai H, Zang J, Liu Y, Tsang C-K, et al. HMG-CoA reductase inhibitors attenuate neuronal damage by suppressing oxygen glucose deprivation-induced activated microglial cells. Neural Plast. 2019; 2019:7675496. doi: 10.1155/2019/7675496 LuD ShenL MaiH ZangJ LiuY TsangC-K HMG-CoA reductase inhibitors attenuate neuronal damage by suppressing oxygen glucose deprivation-induced activated microglial cells Neural Plast 2019 2019 7675496 10.1155/2019/7675496 639798230911291 Open DOISearch in Google Scholar

[40] Li HH, Lin CL, Huang CN. Neuroprotective effects of statins against amyloid b-induced neurotoxicity. Neural Regen Res. 2018; 13:198–206. LiHH LinCL HuangCN Neuroprotective effects of statins against amyloid b-induced neurotoxicity Neural Regen Res 2018 13 198 206 10.4103/1673-5374.226379587988229557360 Search in Google Scholar

[41] Barone E, Cenini G, Di Domenico F, Martin S, Sultana R, Mancuso C, et al. Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. Pharmacol Res. 2011; 63:172–80. BaroneE CeniniG Di DomenicoF MartinS SultanaR MancusoC Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action Pharmacol Res 2011 63 172 80 10.1016/j.phrs.2010.12.007303481021193043 Search in Google Scholar

[42] Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Bäumer AT, et al. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol. 2002; 22:300–5. WassmannS LaufsU MullerK KonkolC AhlboryK BäumerAT Cellular antioxidant effects of atorvastatin in vitro and in vivo Arterioscler Thromb Vasc Biol 2002 22 300 5 10.1161/hq0202.10408111834532 Search in Google Scholar

[43] Farmer JA, Torre-Amione G. Comparative tolerability of the HMG-CoA reductase inhibitors. Drug Saf. 2000; 23:197–213. FarmerJA Torre-AmioneG Comparative tolerability of the HMG-CoA reductase inhibitors Drug Saf 2000 23 197 213 10.2165/00002018-200023030-00003 Search in Google Scholar

[44] Wong ST, Athos J, Figueroa XA, Pineda VV, Schaefer ML, Chavkin CC, et al. Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron. 1999; 23:787–98. WongST AthosJ FigueroaXA PinedaVV SchaeferML ChavkinCC Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP Neuron 1999 23 787 98 10.1016/S0896-6273(01)80036-2 Search in Google Scholar